| Income Statement | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-09-30 |
|---|---|---|---|---|
| Total revenues | 5,143 | 5,007 | 4,777 | 4,863 |
| Cost of sales-Product | 2,270 | 2,160 | 1,963 | 2,033 |
| Cost of sales-Service | 884 | 863 | 802 | 805 |
| Gross profit | 1,990 | 1,985 | 2,012 | 2,026 |
| Selling, general, and administrative | 1,045 | 1,029 | 1,040 | 1,034 |
| Research and development | 292 | 302 | 344 | 316 |
| Total operating expenses | 1,337 | 1,331 | 1,383 | 1,350 |
| Operating income | 653 | 654 | 629 | 676 |
| Interest and other financial charges net | 111 | 113 | 110 | 130 |
| Non-operating benefit (income) costs | -75 | -73 | -74 | -102 |
| Other (income) expense net | 26 | -1 | 99 | 9 |
| Income before income taxes | 643 | 613 | 692 | 658 |
| Benefit (provision) for income taxes | 179 | 113 | 104 | 168 |
| Net income from continuing operations | - | - | - | 490 |
| Income (loss) from discontinued operations, net of taxes | - | - | - | 0 |
| Net income | 464 | 500 | 588 | 490 |
| Net (income) loss attributable to noncontrolling interests | 18 | 14 | 24 | 19 |
| Net income attributable to ge healthcare | 446 | 486 | 564 | 470 |
| Deemed preferred stock dividend of redeemable noncontrolling interest | - | - | - | 0 |
| Net income attributable to ge healthcare common stockholders | - | - | - | 470 |
| Basic (in dollars per share) | 0.98 | 1.06 | 1.23 | 1.03 |
| Basic (in shares) | 456,000,000 | 457,000,000 | 457,000,000 | 457,000,000 |
| Diluted (in dollars per share) | 0.98 | 1.06 | 1.23 | 1.02 |
| Diluted (in shares) | 457,000,000 | 458,000,000 | 459,000,000 | 459,000,000 |
GE HealthCare Technologies Inc. (GEHC)
GE HealthCare Technologies Inc. (GEHC)